EBC – European Brain Council
Brain Awareness Week 2018: Expanding brain research in Europe – Education, Behavior and Brain Development
15 March 2018 – European Parliament, Strasbourg, France
Co-hosted by MEPs Anne Sander (France, EPP), Daciana Sârbu (Romania, S&D) and… Continue Reading
EAN Congress 2025 relocated to HELSINKI due to UN summit (dates remain 21-24 June)
September 20, 2024
Due to unforeseen developments, the 11th Congress of the European Academy of Neurology has been relocated and will now be held in Helsinki on June 21-24, 2025.
EAN co-hosting G7 side-event in Ancona, Italy, on 8 October
September 13, 2024
Upcoming Joint Sessions at Partner Societies’ Congresses
August 26, 2024
Latest Posts
-
-
Gunhild Waldemar (GW): Can you please tell the EAN Pages readers about the goals of the BioMed Alliance and the criteria that need to be fulfilled in order to become a member of the BioMed Alliance? Axel Pries (AP): The Association’s principal goals and objectives are to promote the best interests and values of researchers, of healthcare professionals, and of non-for-profit medical associations and organisations across all medical disciplines in Europe, in those general areas of common interest.
-
EFNAOther News
News from EFNA: EAMDA – European Alliance of Muscular Disorders Associations
March 1, 2018EAMDA is the European Alliance of Neuromuscular Disorders Associations and works to support and improve the quality of everyday life of people with neuromuscular disorders (NMDs). -
by Anna Sauerbier EC Transparency Register The transparency register is a database that lists organisations that try to influence the law-making and policy implementation process of the EU institutions. The register makes… Continue Reading
-
Resident and Research FellowsEducation cornerEducation
RRFS Report: Annual Meeting of French young neurologists and neurology residents in Paris
March 1, 2018This year the conference of French neurology residents and young neurologists (“Les journées des Jeunes Neurologues et de la Recherche Clinique, les J2N”) took place in Paris, France, on February 2-3. -
Fellowship reportsEducation cornerInterviewsEducationTop Articles
Interview with Prof. Anthony Pereira and Prof. Mark Edwards – directors of one of the 6 most popular Clinical Fellowship host departments
March 1, 2018Eveline Sipido: Thank you for hosting applicants of the EAN Clinical Fellowship. How would you evaluate this EAN educational opportunity? Mark Edwards (ME)/Anthony Pereira (AP): St George’s runs one of the largest Neurology & Stroke training schemes in the UK. We cover the UK curriculum on site and so can provide a comprehensive clinical training in neurology and stroke medicine. -
The next Exam of the European Board of Neurology (EBN) will take place on Friday June 15th at the EAN congress site in Lisbon. Since Prof. Wolfgang Grisold from Vienna successfully started this yearly event in 2009 we are now… Continue Reading
-
This year, the “History of Neuroscience Visit” will be at the Egas Moniz Museum: (€30 fee/€ 20 reduced fee) The participants of the History of Neuroscience Visit will be picked up by bus at 13.00h on Monday, June 18. All… Continue Reading
-
EAN NewsInterviewsTop Articles
Interview with Prof. Segolene Aymé, Founder of Orphanet
March 1, 2018Antonio Federico (AF): Dear Professor, you founded Orphanet and gave a great contribution on the development of information about Rare Diseases in Europe. Can you summarize your past activities and the difficulties you had? Segolene Aymé (SA): That is a long story as I started to build a database of genetic diseases and of malformation syndromes described in the literature, in the mid-seventies, when I started as a clinician in medical genetics, lost in diagnosing most of the patients attending our clinic in Marseilles. -
Elena Moro: Dear Prof. Vincent, you have recently been awarded with the WFN Medal for Scientific Achievement in Neurology. We congratulate with you for this well-deserved outstanding recognition! In light of your longstanding experience in the world of neuro-immunology in particular, what do you think is it the most recent important discovery in your field? Angela Vincent (AV): Well first of all thank you for the congratulations. I am thrilled to receive the WFN Medal and it is much appreciated. Neuroimmunology is a relatively recent discipline – probably only first defined in the 1980s.
-
The Republic of Lithuania is a state in northern-eastern Europe occupying 65.300 km2 area with Vilnius city as capital and a population of 2.979.000 inhabitants. Neighbors of Lithuania are Latvia, Belarus, Poland, and Russia. It is a parliamentary democracy, with… Continue Reading
-
As in the previous years, EANpages asked EAN committee members, panel chairs, and invited speakers which session one should not miss at the upcoming congress in Lisbon 2018. Please find their answers below!
-
Paper of the MonthFeatured Slider
Paper of the month: No benefit from solanezumab in Alzheimer disease
March 1, 2018by Elena Moro For March 2018, we have selected: Honig LS, Vellas B, Woodward M, et al. Trial of solanezumab for mild dementia due to Alzheimer’s disease. N Engl J Med 2018;378:321-330. Alzheimer’s disease (AD) pathology can be related to either excessive production or reduced elimination of beta amyloid (Aβ), which eventually results in oligomers, fibrils, and neuritic Aβ plaques. -
EAN NewsEAN Congress newsFeatured Slider
Neurological news from Portugal III – Corina de Andrade and Paramyloidosis
March 1, 2018Prof. Corino de Andrade graduated at Lisbon Medical School, Hospital of St Martha, in 1929. He began his practice at the main hospital in Lisbon (Hospital S. José) and kept visiting his Alma Mater with a serious commitment to practice neurology at the department of Egas Moniz, the only one in Portugal. This passion was soon rewarded with the residency in neurology. -
ResearchInterviewsScientific CornerTop Articles
Rare Disease Day: Interview with Holm Graessner, Coordinator Rare Neurologic Diseases European Reference Network
February 28, 2018Antonio Federico (AF): On January 29-30, there has been in Tubingen the Kick-Off Meeting of the EU Project Solve-RD. You and Prof. Olaf Riess are coordinating this project. Can you summarize the aim and the activities of this important project? Holm Graessner (HG): To obtain a molecularly confirmed diagnosis remains one of the largest challenges for rare disease patients. To jointly tackle this challenge a core group of four European Reference Networks including the European Reference Network for Rare Neurological Diseases has motivated, designed and put together the Solve-RD project which is the first ERN based H2020 funded research project. Solve-RD brings together 21 partners from 10 countries which will be running from 2018 to 2022.